KMS Medisurgi Limited (BOM:540468)
India · Delayed Price · Currency is INR 132.80
+6.30 (4.98%)
At close: May 13, 2026
KMS Medisurgi Revenue
In the fiscal year ending March 31, 2026, KMS Medisurgi had annual revenue of 122.19M INR, down -12.34%. KMS Medisurgi had revenue of 66.17M in the half year ending September 30, 2025, a decrease of -7.49%.
Revenue
122.19M
Revenue Growth
-12.34%
P/S Ratio
3.59
Revenue / Employee
6.11M
Employees
20
Market Cap
438.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 122.19M | -17.20M | -12.34% |
| Mar 31, 2025 | 139.39M | 540.00K | 0.39% |
| Mar 31, 2024 | 138.85M | 28.57M | 25.91% |
| Mar 31, 2023 | 110.27M | 7.10M | 6.88% |
| Mar 31, 2022 | 103.17M | 28.07M | 37.38% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sagarsoft (India) | 1.64B |
| Stanbik Agro | 858.95M |
| Relicab Cable Manufacturing | 642.06M |
| Goldline Pharmaceutical | 280.56M |
| Crestchem | 266.14M |
| Pratik Panels | 107.89M |
| India Home Loan | 75.49M |
| Salem Erode Investments | 18.18M |